Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic-type tinea pedis

Mycoses
Izumi KikuchiS Kawana

Abstract

To study and establish an optimal administration method of oral antifungal, terbinafine (TBF), for hyperkeratotic-type tinea pedis from the pharmacokinetic point of view, 20 patients with hyperkeratotic-type tinea pedis were given TBF 125 mg once daily for 4 weeks and observed over time for improvement of dermatological symptoms and mycological efficacy. Targeting five of the patients, TBF concentration in the stratum corneum was measured using the LC-MS/MS method. TBF was detected in the stratum corneum of the sole 1 week after beginning the treatment in some cases and reached its peak 1 week after the completion of the treatment with a concentration of 247.8 ng g(-1), which was approximately more than 50 times higher than its minimal inhibitory concentration against dermatophytes. TBF was not detected at 8 weeks post-treatment, although its concentration was 50.73 ng g(-1) at 6 weeks post-treatment. All cases were subjected to analysis for final total efficacy, general safety and usefulness. Its effectiveness rate (effective + markedly effective) was 95% (19/20) with no adverse reactions, including abnormal changes in the laboratory test values, in any patients. From the above, it is noted that TBF showed excellent efficacy a...Continue Reading

References

Feb 1, 1992·The British Journal of Dermatology·N S Ryder
Sep 1, 1991·The British Journal of Dermatology·J E WhiteE G Evans
Oct 1, 1990·Journal of the American Academy of Dermatology·R C Savin, N Zaias
Oct 1, 1990·Journal of the American Academy of Dermatology·R C Savin
Mar 1, 1989·Clinical and Experimental Dermatology·R Savin
Jul 1, 1993·Journal of the American Academy of Dermatology·R J Hay
Feb 26, 1998·Mycoses·H Tanuma, S Nishiyama
May 16, 1998·International Journal of Dermatology·I TauschA Del Palacio
Jun 1, 2002·Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology·Taizo Hamaguchi, Iwao Takiuchi

❮ Previous
Next ❯

Citations

Jun 15, 2011·Mycoses·Lauren Van Duyn Graham, Boni E Elewski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.